Plavix Tablets (Clopidogrel Hydrogen Sulfate)

Adult dose

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg of this medicine once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ～ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ～ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment : Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment : Experience with treatment in patients with moderate hepatic disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

This medication prevents platelets from clumping together, helping the blood flow properly. Consult a physician if you have a genetic deficiency in the function of a specific enzyme (CYP2C19), as it may reduce the effectiveness of the drug. Avoid using this drug in combination with medications that activate the CYP2C19 enzyme, as it may increase the risk of bleeding. This drug should not be used in patients with allergies to specific components, those with bleeding disorders, patients with severe liver impairment, breastfeeding women, or patients with lactose intolerance. Patients with a high risk of bleeding, diminished liver or kidney function, elderly patients, underweight patients, and those with specific allergy histories should use this drug with caution. If bleeding symptoms occur while taking this medication, consult a physician immediately, and notify your physician if surgery is planned. This medication may increase the risk of bleeding when taken with other drugs that have bleeding risks, anticoagulants, or antiplatelet agents, so caution is needed. During pregnancy, the risk to the fetus is not clearly established; however, it may be needed in emergencies and should be discontinued before delivery due to bleeding risks. In breastfeeding cases, since this drug may be excreted in breast milk, the decision to use it should be made after consulting a physician. Safety for pediatric use has not been established. In cases of overdose, the risk of bleeding may increase, so the prescribed dosage must be strictly followed. This drug should be stored out of reach of children and not transferred to other containers.

Hemorrhage, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, severe neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, depression, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, chest pain, traumatic injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, hypercholesterolemia, arthralgia, low back pain, depression, upper respiratory tract infection, rash, pruritus, urinary tract infection, syncope, palpitations, asthenia, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory disturbance, neuralgia, paresthesia, vertigo, constipation, vomiting, increased liver enzymes, gout, hyperuricemia, non-protein nitrogen increase, arthritis, arthrosis, anxiety, insomnia, anemia, melena, thrombocytopenia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, allergic symptoms, ischemic necrosis, generalized edema, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, bloating, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, thrombocytopenia, aplastic anemia, hypochromic anemia, leukemia, leukopenia, neutropenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythema multiforme, papular rash, urticaria, renal dysfunction, acute renal failure, loss of appetite, weight loss, visual disturbances, hypesthesia, weight gain, facial flushing, decreased motor function, thirst, memory loss, abnormal thoughts, polyuria, arrhythmia, tremor, vocal cord dysfunction, abnormal gait, hyperactivity, ataxia, hiccups, dysphagia, tongue disorders, abnormal behavior, rigidity, visual field defects, dry eye syndrome, temporary blindness, congestion, urination disorders, uremia, hypoglycemia, bradycardia, tinnitus, contact dermatitis, gynecomastia, elevated PSA, cholecystitis, hematemesis, spinal hematoma, thrombocytopenia, thrombocytopenia, thrombocytopenia

This medication should be stored in a sealed container to protect from air and moisture. Additionally, it should be kept at room temperature, not too cold or too hot, ideally between 1 to 30 degrees Celsius.

Appearance

Pink, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle